These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8300199)

  • 21. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
    Novak-Weekley SM; Hollingsworth MH
    Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.
    Sougioultzis S; Kyne L; Drudy D; Keates S; Maroo S; Pothoulakis C; Giannasca PJ; Lee CK; Warny M; Monath TP; Kelly CP
    Gastroenterology; 2005 Mar; 128(3):764-70. PubMed ID: 15765411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.
    Yang Z; Ramsey J; Hamza T; Zhang Y; Li S; Yfantis HG; Lee D; Hernandez LD; Seghezzi W; Furneisen JM; Davis NM; Therien AG; Feng H
    Infect Immun; 2015 Feb; 83(2):822-31. PubMed ID: 25486992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic role of endoscopy, stool culture, and toxin A in Clostridium difficile-associated disease.
    Wei SC; Wong JM; Hsueh PR; Shieh MJ; Wang TH; Luh KT; Wang CY
    J Formos Med Assoc; 1997 Nov; 96(11):879-83. PubMed ID: 9409120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.
    Johnson S; Sypura WD; Gerding DN; Ewing SL; Janoff EN
    Infect Immun; 1995 Aug; 63(8):3166-73. PubMed ID: 7622244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G; Muller MC; Wilkins TD; Lyerly D; L'Haridon R
    Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a new serological assay for the diagnosis of Clostridium difficile infections with prognostic value.
    von Bechtolsheim F; Varga A; Szereday L; Polgar B; Balassa T; Kocsis B; Peterfi Z; Miko E
    J Microbiol Methods; 2019 Dec; 167():105777. PubMed ID: 31733265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls.
    Sánchez-Hurtado K; Corretge M; Mutlu E; McIlhagger R; Starr JM; Poxton IR
    J Med Microbiol; 2008 Jun; 57(Pt 6):717-724. PubMed ID: 18480328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A.
    Warny M; Denie C; Delmée M; Lefebvre C
    Acta Clin Belg; 1995; 50(1):36-9. PubMed ID: 7537003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of Clostridium difficile toxin A using antibody combinations.
    Demarest SJ; Hariharan M; Elia M; Salbato J; Jin P; Bird C; Short JM; Kimmel BE; Dudley M; Woodnutt G; Hansen G
    MAbs; 2010; 2(2):190-8. PubMed ID: 20150758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Six years evaluation of Clostridium difficile associated diarrhea].
    Ercis S; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of biotherapeutics on antitoxin IgG in experimentally induced Clostridium difficile infection.
    Kaur S; Vaishnavi C; Kochhar R; Prasad KK; Ray P
    Indian J Med Microbiol; 2012; 30(4):431-6. PubMed ID: 23183468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.
    Torres JF; Lyerly DM; Hill JE; Monath TP
    Infect Immun; 1995 Dec; 63(12):4619-27. PubMed ID: 7591115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.
    Cook L; Rees WD; Wong MQ; Peters H; Levings MK; Steiner TS
    Gastroenterology; 2021 May; 160(6):2155-2158.e4. PubMed ID: 33444574
    [No Abstract]   [Full Text] [Related]  

  • 36. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
    Kelly CP; Pothoulakis C; Orellana J; LaMont JT
    Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
    Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
    Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
    Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
    J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.
    Gardiner DF; Rosenberg T; Zaharatos J; Franco D; Ho DD
    Vaccine; 2009 Jun; 27(27):3598-604. PubMed ID: 19464540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.
    DiPersio JR; Varga FJ; Conwell DL; Kraft JA; Kozak KJ; Willis DH
    J Clin Microbiol; 1991 Dec; 29(12):2724-30. PubMed ID: 1757540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.